Nantahala Capital Management - ELOXX PHARMACEUTICALS INC ownership

ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 40 filers reported holding ELOXX PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 2.09 and the average weighting 0.0%.

Quarter-by-quarter ownership
Nantahala Capital Management ownership history of ELOXX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$434,000
-31.3%
774,767
-13.4%
0.02%
-13.6%
Q4 2021$632,000
-67.9%
894,659
-26.0%
0.02%
-64.5%
Q3 2021$1,971,000
-56.3%
1,209,338
-46.6%
0.06%
-51.6%
Q2 2021$4,510,0002,266,2870.13%
Other shareholders
ELOXX PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 1,930,092$1,363,0000.55%
AMERICAN FINANCIAL GROUP INC 1,480,000$1,045,0000.29%
Vanguard Capital Wealth Advisors 158,900$111,0000.08%
Anson Funds Management LP 553,652$391,0000.04%
Nantahala Capital Management 894,659$632,0000.02%
MENORA MIVTACHIM HOLDINGS LTD. 2,094,208$1,479,0000.02%
Harel Insurance Investments & Financial Services Ltd. 1,176,401$831,0000.02%
Atom Investors LP 113,151$80,0000.01%
Virtu Financial LLC 130,270$91,0000.01%
Altshuler Shaham Ltd 1,157,540$828,0000.01%
View complete list of ELOXX PHARMACEUTICALS INC shareholders